{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:27:36Z","timestamp":1789000056011,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.nmd.2010.11.015","type":"journal-article","created":{"date-parts":[[2011,2,5]],"date-time":"2011-02-05T04:23:37Z","timestamp":1296879817000},"page":"194-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies"],"prefix":"10.1016","volume":"21","author":[{"given":"Harriet P.","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Mirabella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Domazetovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Petrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza Maria","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra T.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn N.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2010.11.015_b0005","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.52.7.1453","article-title":"Phenotypic variability in rippling muscle disease","volume":"52","author":"Vorgerd","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.11.015_b0010","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.62.4.538","article-title":"Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases","volume":"62","author":"Woodman","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.11.015_b0015","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/mus.1180","article-title":"Severe autosomal recessive rippling muscle disease","volume":"24","author":"Koul","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2010.11.015_b0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.20350","article-title":"Autosomal recessive rippling muscle disease with homozygous CAV3 mutations","volume":"57","author":"Kubisch","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2010.11.015_b0025","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2010.11.015_b0030","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1212\/01.WNL.0000068529.36993.03","article-title":"Autoimmune rippling muscle","volume":"61","author":"Ashok Muley","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.11.015_b0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2169\/internalmedicine.41.147","article-title":"Rippling muscle syndrome preceding malignant lymphoma","volume":"41","author":"Takagi","year":"2002","journal-title":"Internal Med"},{"key":"10.1016\/j.nmd.2010.11.015_b0040","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.53.6.1233","article-title":"Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability","volume":"53","author":"Vernino","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.11.015_b0045","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mus.10266","article-title":"Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability","volume":"26","author":"Vernino","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2010.11.015_b0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2009.01.002","article-title":"Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two","volume":"19","author":"Schoser","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2010.11.015_b0055","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.WNL.0000149532.52938.5B","article-title":"Immune-mediated rippling muscle disease","volume":"64","author":"Schulte-Mattler","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.11.015_b0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nmd.2007.08.009","article-title":"Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis","volume":"18","author":"Lo","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2010.11.015_b0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.WNL.0000069460.53438.38","article-title":"Single section Western blot: improving the molecular diagnosis of the muscular dystrophies","volume":"61","author":"Cooper","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.11.015_b0070","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.nmd.2007.04.010","article-title":"Ullrich myopathy phenotype with secondary ColVI defect identified by confocal imaging and electron microscopy analysis","volume":"17","author":"Petrini","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2010.11.015_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10974-008-9145-x","article-title":"Myosin as a potential redox-sensor: an in vitro study","volume":"29","author":"Passarelli","year":"2008","journal-title":"J Muscle Res Cell Mot"},{"key":"10.1016\/j.nmd.2010.11.015_b0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nmd.2008.05.003","article-title":"Caveolinopathy \u2013 new mutations and additional symptoms","volume":"18","author":"Aboumousa","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2010.11.015_b0085","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/hum.1997.8.12-1429","article-title":"Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy","volume":"8","author":"Decary","year":"1997","journal-title":"Hum Gen Ther"},{"key":"10.1016\/j.nmd.2010.11.015_b0090","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.nmd.2006.12.010","article-title":"Dystrophinopathy carrier determination and detection of protein deficiencies in muscular dystrophy using lentiviral MyoD-forced myogenesis","volume":"17","author":"Cooper","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2010.11.015_b0095","series-title":"Duchenne muscular dystrophy: advances in therapeutics","first-page":"105","article-title":"Protein studies in Duchenne muscular dystrophy","author":"Cooper","year":"2006"},{"key":"10.1016\/j.nmd.2010.11.015_b0100","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/hmg\/10.17.1761","article-title":"The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle","volume":"10","author":"Matsuda","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2010.11.015_b0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0022-510X(91)90069-J","article-title":"Characterisation of dystrophin in carriers of Duchenne muscular dystrophy","volume":"102","author":"Clerk","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2010.11.015_b0110","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/WNL.45.4.677","article-title":"Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei","volume":"45","author":"Pegoraro","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2010.11.015_b0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ng1294-323","article-title":"Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy","volume":"8","author":"Bione","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.nmd.2010.11.015_b0120","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/MCB.02186-07","article-title":"MURC, a muscle-restricted coiled-coil protein that modulates the Rho\/ROCK pathway, induces cardiac dysfunction and conduction disturbance","volume":"28","author":"Ogata","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.nmd.2010.11.015_b0125","doi-asserted-by":"crossref","first-page":"11321","DOI":"10.1074\/jbc.273.18.11321","article-title":"Evidence for in situ and in vitro association between beta-dystroglycan and the subsynaptic 43K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse","volume":"273","author":"Cartaud","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2010.11.015_b0130","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/339465","article-title":"Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome","volume":"70","author":"Ohno","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2010.11.015_b0135","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.20307","article-title":"Rippling muscle disease may be caused by \u201csilent\u201d action potentials in the tubular system of skeletal muscle fibers","volume":"31","author":"Lamb","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2010.11.015_b0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/geno.1998.5689","article-title":"Physical mapping of the rippling muscle disease locus","volume":"55","author":"Stephan","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.nmd.2010.11.015_b0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.1996.00550020113023","article-title":"Rippling muscles and myasthenia gravis with rippling muscles","volume":"53","author":"Ansevin","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2010.11.015_b0150","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1083\/jcb.200903053","article-title":"MURC\/Cavin-4 and cavin family members form tissue-specific caveolar complexes","volume":"185","author":"Bastiani","year":"2009","journal-title":"J Cell Biol"},{"key":"10.1016\/j.nmd.2010.11.015_b0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000212371","article-title":"Myasthenia gravis with anti-acetylcholine receptor antibodies","volume":"26","author":"Meriggioli","year":"2009","journal-title":"Front Neurol Neurosci"},{"key":"10.1016\/j.nmd.2010.11.015_b0160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2010.11.015_b0165","doi-asserted-by":"crossref","first-page":"38048","DOI":"10.1074\/jbc.M005321200","article-title":"Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members","volume":"275","author":"Sotgia","year":"2000","journal-title":"J Biol Chem"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610006711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896610006711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:58:41Z","timestamp":1760774321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896610006711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0960896610006711"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2010.11.015","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2010.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}